Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy

SAN JOSE, Calif.: SAN JOSE, Calif., Oct. 1, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance broadening protection of...

Click to view original post